Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
19 Settembre 2023 - 4:48PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant To Section 14(a) of the Securities Exchange Act of 1934
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
☐ |
Preliminary Proxy Statement |
☐ |
Confidential, for Use of the Commissions Only (as permitted
by Rule 14a-6(e)(2)) |
☐ |
Definitive Proxy Statement |
☒ |
Definitive Additional Materials |
☐ |
Soliciting Material Pursuant to Section 240.14a-12 |
MICROBOT
MEDICAL INC. |
(Name of Registrant as Specified
in its Charter) |
N/A |
(Name of Person(s) Filing
Proxy Statement, if other than the Registrant) |
Payment
of Filing Fee (Check all boxes that apply):
☒ |
No fee required. |
|
|
☐ |
Fee paid previously with preliminary materials |
|
|
☐ |
Fee computed on table in exhibit required by Item 25(b)
per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Grafico Azioni Microbot Medical (NASDAQ:MBOT)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Microbot Medical (NASDAQ:MBOT)
Storico
Da Mag 2023 a Mag 2024